Eli Lilly filed a complaint with the U.S. International Trade Commission to block companies from importing and selling cheaper versions of its hit drug Mounjaro.
Eli Lilly filed a complaint with the U.S. International Trade Commission on Thursday to block companies from importing and selling cheaper versions of its blockbuster drug Mounjaro online, accusing them of misleading and endangering American consumers seeking to lose weight.
The complaint to the trade commission, however, targets companies that sell their compounds directly to consumers online, often without a prescription that would be required for Mounjaro and other FDA-approved drugs. Lilly is seeking an order from the federal agency that would bar all imports of products that violate fair trade provisions, such as the infringing of its trademark, as well as cease-and-desist orders to the individual companies it has targeted.
Mounjaro, Ozempic and Wegovy have proven so popular that their manufacturers haven’t been able to keep up with demand, leading the FDA to declare the drugs in short supply. Thathas opened the door for compounding pharmacies to mix up versions of the FDA-approved drugs, giving rise to an industry built on selling the off-brand versions far more cheaply.Lilly emphasized in the complaint that it has invested heavily in expanding capacity to make Mounjaro.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
2 Stocks Set to Capitalize on the Surging Weight Loss Drug TrendStocks Analysis by The Tokenist (Timothy Fries) covering: Eli Lilly and Company, Novo Nordisk A/S. Read The Tokenist (Timothy Fries)'s latest article on Investing.com
Read more »
‘Thanksgiving’ Teaser — Scares Are on the MenuEli Roth's holiday horror flick Thanksgiving, starring Patrick Dempsey, has released a new teaser.
Read more »
New Thanksgiving Promo Teases Eli Roth Delivering a Holiday LegendA new slasher stalks the streets in the promo.
Read more »
Sanofi to offer insulin product for $35 to all Americans through GoodRxThe effort comes after Sanofi, Eli Lilly and Novo Nordisk announced sweeping insulin price cuts earlier this year.
Read more »
Sanofi to offer insulin product for $35 to all Americans through GoodRxThe effort comes after Sanofi, Eli Lilly and Novo Nordisk announced sweeping insulin price cuts earlier this year.
Read more »
Taking a New Obesity Drug and Birth Control Pills? Be CarefulMany women on oral contraceptives are unaware that drugs like Mounjaro may result in the unexpected: pregnancy.
Read more »